Teva agrees to fork over $750M to close the book on years of tax litigation in Israel
Fierce Pharma
JUNE 25, 2024
< | The deal with the Israel Tax Authority wraps up pending litigation over taxes payable from 2008 to 2020. With an agreement to make payments totaling $750 million over the next five years, Teva can wipe its slate clean of litigation from Israeli regulators that concerns over a decade's worth of taxes.<
Let's personalize your content